Delivery Order SPE2DB20D6035-SPE2DB25FLYEV
- Not listed
- The Defense Logistics Agency awarded a $3,539.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Methylergonovine 0.2 mg tablets in packages of 12. The contract, with an ultimate completion date of September 19, 2025, represents a non-competitive, non-set-aside procurement delivered from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for methylergonovine 0.2 mg/mL in a one-milliliter volume on July 9, 2025, with a ceiling value of $4,786.56. This firm fixed-price delivery order, which completes on July 10, 2025, represents a non-competitive set-aside award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg tablets (28-count packages) with a ceiling value of $3,229.90. The contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was awarded on July 31, 2025. Performance will take place at the company's Corporate Office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylergonovine 0.2 mg tablets in quantities of 12 units, with a ceiling value of $1,209.92. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside competitive award. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/ml in ampule form, valued at $3,170.91 with a firm fixed price arrangement. The contract is unclassified as a set-aside and was awarded on August 3, 2025, with an ultimate completion date of August 4, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count) with a firm fixed price ceiling value of $1,547.44. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion on August 22, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylergonovine 0.2 mg/mL in ampule form, with a firm fixed price ceiling value of $2,015.40 and an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $37,979.91 to AmerisourceBergen Drug Corp for the supply of methylergonovine 0.2 mg tablets in unit dose packaging of 20 tablets. This competitive award, issued on May 6, 2025, with an ultimate completion date of May 7, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a $1,602.15 delivery order to AmerisourceBergen Drug Corp for Methylergonovine 0.2 mg/mL on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract procures a pharmaceutical product used in obstetric care to prevent and treat postpartum...
- The Defense Logistics Agency awarded a delivery order valued at $1,794.96 to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/mL, a pharmaceutical product used in obstetric care. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a time-sensitive procurement for a critical pharmaceutical...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYEVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,160.58 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Methylergonovine 0.2 mg tablets (28-count packages). This is a firm fixed price, non-set-aside contract with a completion date of August 7, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Methylergonovine is an ergot alkaloid medication commonly used in obstetric and gynecological applications to prevent or treat postpartum hemorrhage, indicating this delivery supports military medical supply chain requirements for clinical pharmaceuticals. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp has established itself as a critical federal vendor supplying a broad range of medications and medical supplies to military and veteran healthcare systems. The company regularly fulfills individual delivery orders for specialty medications, generics, vaccines, and medical devices through competitive procurement processes, supporting the Defense Health Agency and other government healthcare entities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/6/25 |